Mustapha Chamekh

Prof. Mustapha Chamekh

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
MDMaud Deny
Maud Deny
Alexandros PopotasAlexandros Popotas
Alexandros Popotas
LHLaurence Hanssens
Laurence Hanssens
Nicolas LefèvreNicolas Lefèvre
Nicolas Lefèvre
LNLuis Alexis Arroba Nuñez
Luis Alexis Arroba Nuñez
MCMustapha Chamekh
Mustapha Chamekh
Previous studies have reported sex disparity in cystic fibrosis (CF) disease, with females experiencing more pulmonary exacerbations and frequent microbial infections resulting in shorter survival expectancy. This concerns both pubertal and prepubertal females, which is in support to the prominent role of gene dosage rather than the hormonal status. The underlying mechanisms are still poorly understood. The X chromosome codes for a large number of micro-RNAs (miRNAs) that play a crucial role in the post-transcriptional regulation of several genes involved in various biological processes, including inflammation. However, their level of expression in CF males and females has not been sufficiently explored. In this study, we compared in male and female CF patients the expression of selected X-linked miRNAs involved in inflammatory processes. Cytokine and chemokine profiles were also evaluated at both protein and transcript levels and cross-analyzed with the miRNA expression levels. We observed increased expression of miR-223-3p, miR-106a-5p, miR-221-3p and miR-502-5p in CF patients compared to healthy controls. Interestingly, the overexpression of miR-221-3p was found to be significantly higher in CF girls than in CF boys and this correlates positively with IL-1β. Moreover, we found a trend toward lower expression in CF girls than in CF boys of suppressor of cytokine signaling 1 (SOCS1) and the ubiquitin-editing enzyme PDLIM2, two mRNA targets of miR-221-3p that are known to inhibit the NF-κB pathway. Collectively, this clinical study highlights a sex-bias in X-linked miR-221-3p expression in blood cells and its potential contribution to sustaining a higher inflammatory response in CF girls.

30 November 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
MCMustapha Chamekh
Mustapha Chamekh
GCGeorges Casimir
Georges Casimir
Editorial: Sexual dimorphism of the immune inflammatory response in infectious and non-infectious diseases, volume II

2 December 2025 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
HBHanane Ben-Taleb
Hanane Ben-Taleb
NANarjis Amar
Narjis Amar
ACAzeddine Chakroun
Azeddine Chakroun
KNKaotar Nayme
Kaotar Nayme
ALAmine Lamrissi
Amine Lamrissi
MCMustapha Chamekh
Mustapha Chamekh
Group B streptococcus (GBS) is a commensal bacterium that can cause severe infection in neonates. Vaginal colonization with GBS is a risk factor for mother

12 June 2026 in BMC Infectious Diseases
Verified
Journal Article
Open access
ACAzeddine Chakroun
Azeddine Chakroun
NANarjis Amar
Narjis Amar
HBHanane Ben-Taleb
Hanane Ben-Taleb
KMKarima Mohtadi
Karima Mohtadi
ALAmine Lamrissi
Amine Lamrissi
MCMustapha Chamekh
Mustapha Chamekh
The transmission of pathogenic Gram-negative bacteria such as Escherichia coli and Klebsiella pneumoniae from mother to child during pregnancy contributes significantly to neonatal morbidity and mortality, particularly in low and middle-income countries. Identifying maternal risk factors associated with vertical transmission is crucial. This prospective study aimed to investigate the maternal cytokine profile and anti-LPS-specific antibodies in pregnant mothers with positive cultures for E. coli and K. pneumoniae, exploring their potential association with neonatal invasive disease. This prospective study examined groups of pregnant women with a positive culture for E. coli or K. pneumoniae, who had or had not given birth to newborns with invasive diseases. A group of age-matched mothers negative for E coli and K. pneumoniae was used as a control. A panel of circulating inflammatory cytokines was measured in mother-infant dyads using Luminex multiplex assays or ELISA in maternal and cord blood, as well as in the supernatants of blood leucocytes stimulated with TLR4 and TLR1/2 ligands. The serum levels of specific IgG anti-LPS E. coli and anti-LPS K. pneumoniae were quantified using ELISA. Mothers with a positive culture for E. coli and K. pneumoniae and their newborns exhibited elevated plasma levels of IL-6, IL-8, and TNF-α compared to healthy mothers and their newborns. Similar results were observed for IL-6 and TNF-α when blood leucocytes were stimulated by TLR4 and TLR1/2 ligands. Mothers who gave birth to newborns with severe infectious diseases had higher IL-6 levels and lower specific IgG anti-LPS E. coli or anti-LPS K. pneumoniae levels compared to those with healthy newborns. Receiver operating characteristic (ROC) analysis demonstrated a strong association between maternal IL-6 and specific IgG levels and perinatal bacterial transmission. Pregnant women with positive cultures for E. coli or K. pneumoniae, as well as higher plasma levels of IL-6 and lower levels of specific anti-bacterial IgG, are at increased risk of perinatal bacterial transmission. This data could help improve the monitoring of mother-child dyads and optimize prenatal care. Clinical trial number: not applicable.